FOXM1 has also been shown to promote taxane resistance in breast cancer [216,264,265], gastric cancer [266,267,268], hepatocellular carcinoma [269], prostate cancer [270], and nasopharyngeal carcinoma [271]. The gene discussed is FOXM1; the disease is hepatocellular carcinoma.